News & Events

News & Events

Latest

Michael LeBlanc
Michael LeBlanc
Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma
SWOG Cancer Research Network,

Two years after starting treatment, patients with stage 3-4 classic Hodgkin lymphoma treated with nivolumab plus AVD chemotherapy had roughly one-half the risk of progression or death of those who had a standard treatment of brentuximab vedotin plus AVD. 

“This new analysis with more patient follow-up is critical to understanding the clinically meaningful benefit obtained from N-AVD compared to BV-AVD,” said Michael LeBlanc, PhD, lead biostatistician on the S1826 study and a UW professor of biostatistics.

Available for 2024 Pre-Application Review Services for PhD applicants in Biostatistics and Statistics at UW
Available for 2024 Pre-Application Review Services for PhD applicants in Biostatistics and Statistics at UW
Pre-application review service for PhD applicants offers mentorship to historically marginalized groups
Service available beginning October 2 for PhD applicants
Photo of Lianne Sheppard sitting on a bench
Photo of Lianne Sheppard sitting on a bench
Get to know new interim DEOHS Chair Lianne Sheppard
Department of Environmental and Occupational Health Sciences,

Lianne Sheppard, new DEOHS interim chair, looks to build community, support faculty as she steps into new role. Sheppard is also a professor of biostatistics.

Amy Willis
Amy Willis
Amy Willis receives $299k NSF grant to develop a novel method to estimate bacterial evolutionary histories
Associate Professor of Biostatistics Amy Willis to develop and study a novel method to estimate bacterial evolutionary histories with $299k from the National Science Foundation.
Sharon Browning and Brian Browning
Sharon Browning and Brian Browning
FLARE extracts genetic insights from hundreds of millions of data points
A new method called FLARE was developed by UW Professor of Biostatistics Sharon Browning because existing software for inferring local ancestry was not able to handle the increasingly large amounts of genetic data that are available.